Ventas Coverage Assumed by Wells Fargo at Overweight Vs Previous Rating of Equal-Weight
Ventas Analyst Ratings
Wells Fargo Upgrades 3, Downgrades 2 Healthcare REITs on Price to Earnings Growth and Yield
Wells Fargo Upgrades Ventas Inc(VTR.US) to Buy Rating, Raises Target Price to $71
Ventas (VTR) Was Upgraded to a Buy Rating at Wells Fargo
Mizuho Securities Initiates Ventas Inc(VTR.US) With Buy Rating, Announces Target Price $71
Jefferies Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $73
Jefferies Adjusts Price Target on Ventas to $73 From $66, Maintains Buy Rating
Ventas Is Maintained at Outperform by Evercore ISI Group
Ventas Analyst Ratings
BMO Capital Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $70
Evercore Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $70
JPMorgan Raises Price Target on Ventas to $67 From $50
Ventas Is Maintained at Outperform by Wedbush
Ventas Analyst Ratings
Wedbush Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $71
Citigroup Adjusts Ventas Price Target to $72 From $59
Ventas Is Maintained at Outperform by Evercore ISI Group
Ventas Price Target Raised to $64.00/Share From $61.00 by Evercore ISI Group
Ventas Analyst Ratings